Endocrinology CPT® Codes for 2026 + Modifiers
Feb 5, 2026
Endocrinology billing in 2026 is defined by remote monitoring expansion, stricter documentation requirements, new ICD-10 specificity, and targeted reimbursement adjustments. From continuous glucose monitoring (CGM) to short-duration RPM codes and modifier enforcement, small compliance gaps can now create measurable revenue loss. If your team hasn’t fully adapted to the 2026 updates, denials and underpayments are likely already appearing in your AR.
This guide reviews the most important endocrinology CPT® codes and modifiers for 2026 and highlights the regulatory shifts that directly impact reimbursement, documentation, and compliance workflows.
Endocrinology denials in 2026 are predictable—and preventable.
We’re seeing the same issues repeatedly: RPM claims denied for failing automatic transmission requirements, CGM interpretation underpaid due to missed add-ons, and modifier-related rejections on injectable drugs. These aren’t random payer decisions—they’re workflow gaps.
Guarantee: We’ll identify the top denial drivers in your endocrinology claims and give you a concrete plan to correct them.
Get My Endocrinology Denial Snapshot
Contact us to receive a Denial Snapshot that shows where reimbursement is breaking down—and how to fix it.
Evaluation and Management (E/M) Services
E/M coding for endocrinology continues to rely on Medical Decision Making (MDM) or total time. However, modifier -25 remains under heightened payer scrutiny when billed alongside procedures such as CGM placement, pump adjustments, or injections.
| CPT® Code | Description |
|---|---|
| 99202–99205 | New patient office visits (levels 2–5) |
| 99212–99215 | Established patient office visits (levels 2–5) |
G2211 Add-On for Longitudinal Specialty Care
For patients with chronic endocrine disorders—such as Type 1 diabetes, adrenal insufficiency, or pituitary disorders—G2211 may be appended when documentation reflects ongoing, complex specialty management.
In 2026, this add-on is increasingly important to offset RVU reductions applied to high-volume endocrine services.
If your E/M + procedure claims are denying, it’s usually a documentation separation issue.
We frequently see 99213–99215 denied when modifier -25 is appended without a clearly distinct assessment and plan. Payers expect the E/M “story” to stand alone.
Guarantee: We’ll pinpoint why your E/M claims are under scrutiny and show you exactly what to adjust in documentation.
Contact us for a Denial Snapshot highlighting E/M documentation risks.
Continuous Glucose Monitoring (CGM)
CGM remains central to endocrinology reimbursement, but 2026 introduced an efficiency adjustment that affects high-volume practices.
| CPT® Code | Description |
|---|---|
| 95249 | CGM setup using patient-owned equipment |
| 95250 | CGM setup and sensor placement (clinic-provided device) |
| 95251 | CGM data interpretation and report (minimum 72 hours of data) |
2026 Efficiency Adjustment for 95251
While CPT® 95251 remains unchanged, CMS applied a -2.5% efficiency adjustment. The work RVU decreased from 0.70 to 0.68, creating measurable revenue impact for practices performing high volumes of interpretation.
Ensuring appropriate use of G2211 during complex diabetic management visits can help offset the cumulative impact.
CGM interpretation denials usually stem from missing documentation elements.
We see payers deny 95251 when reports lack documented analysis, treatment adjustments, or evidence of at least 72 hours of data.
Guarantee: We’ll identify the documentation gaps reducing your CGM reimbursement.
Contact us for a Denial Snapshot focused on CGM reimbursement risks.
New 2026 Short-Duration RPM Codes
The most impactful change for endocrinology in 2026 is expansion of the RPM code family to include short-duration monitoring.
| CPT® Code | Description | 2026 Use Case |
|---|---|---|
| 99445 | Remote monitoring device supply (2–15 days) | Short-term insulin titration or temporary monitoring |
| 99454 | Remote monitoring device supply (16+ days) | Full-month monitoring cycle |
Automatic Transmission Requirement
For both 99445 and 99454, the device must transmit data automatically. Manual logs, emailed readings, or spreadsheet uploads do not qualify for device supply billing.
RPM denials in endocrinology are almost always transmission-related.
If documentation doesn’t clearly confirm automatic device transmission, payers reject 99445 and 99454 quickly.
Guarantee: We’ll verify whether your RPM documentation meets CMS transmission standards.
Contact us to evaluate your RPM billing process.
Lower Remote Management Time Threshold
CMS introduced a new lower-intensity management code in 2026 to reflect shorter data review sessions.
| CPT® Code | Description |
|---|---|
| 99470 | Remote monitoring treatment management, 10–19 minutes |
| 99457 | Remote monitoring treatment management, 20+ minutes |
Important Rule: CPT® 99470 and 99457 cannot be billed together in the same calendar month.
Choosing the wrong time-based RPM code triggers avoidable denials.
We see confusion between 99470 and 99457, especially in hybrid months where documentation doesn’t clearly support total time.
Guarantee: We’ll evaluate whether your remote management time tracking supports your claims.
Contact us to assess compliance with RPM time thresholds.
Laboratory and Hormonal Testing
| CPT® Code | Description |
|---|---|
| 84443 | TSH |
| 84439 | Free T4 |
| 84480 | Total T3 |
| 82533 | Cortisol |
| 82043 | Urine microalbumin |
Common ICD-10-CM Codes in Endocrinology
| ICD-10 Code | Description |
|---|---|
| E11.A | Type 2 diabetes mellitus in remission |
| H06.21 | Thyroid eye disease, right eye |
| H06.22 | Thyroid eye disease, left eye |
| H06.23 | Thyroid eye disease, bilateral |
Drug Modifiers and Compliance
| Modifier | When Used |
|---|---|
| -JW | Portion of single-dose drug discarded |
| -JZ | No discarded drug (zero waste) |
Telehealth and Supervision Updates
Virtual direct supervision is now permanent. Supervising endocrinologists may meet supervision requirements through real-time audio/video technology for applicable staff-led services.
2026 Endocrinology Watch List
- Ensure automatic transmission for RPM device supply codes.
- Apply G2211 when longitudinal specialty care is documented.
- Update documentation for diabetes remission (E11.A).
- Append -JZ or -JW on all applicable injectable drug claims.
Final Thoughts
Endocrinology billing in 2026 requires precise documentation, correct RPM code selection, appropriate modifier use, and updated ICD-10 specificity. Small compliance gaps can now produce repeat denials or revenue compression across high-volume CGM and diabetes management services.
If endocrinology denials are increasing, it’s not random—it’s structural.
From CGM RVU reductions to new RPM tiers and mandatory drug modifiers, 2026 changes require workflow precision.
Guarantee: We’ll identify your highest-risk billing areas and provide a step-by-step correction plan.
Get My Endocrinology Denial Snapshot
Contact us today to start reducing denials and protecting reimbursement.
Trademark notice: CPT is a registered trademark of the American Medical Association.
For informational purposes only.
Contact us
“My husband and I have a small practice but we were looking for a medical billing company to consult us. We originally started with a local company with some satisfaction. However, our biggest problem was that they wanted us to change our existing EMR to software that they worked with. Quest National Services worked with our existing software so that we didn’t have to make expensive changes to our infrastructure. That saved us a lot of time and headache. I would definitely say that was one of the main reasons for why we switched and why we continue to work with Quest. As a small practice, they helped us without draining our resources.”
Adriana C.
